- Home
- BDTX vs BMHL Comparison
BDTX vs BMHL Comparison
Compare BDTX & BMHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BDTX | BMHL |
|---|---|---|
| Founded | 2014 | 2016 |
| Country | United States | Hong Kong |
| Employees | N/A | 9 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 116.8M | 91.4M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | BDTX | BMHL |
|---|---|---|
| Price | $3.06 | $3.58 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $9.50 | N/A |
| AVG Volume (30 Days) | ★ 691.3K | 2.3K |
| Earning Date | 05-11-2026 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 130.71 | N/A |
| EPS | ★ 0.39 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $7.85 | $66.66 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.46 | $2.72 |
| 52 Week High | $4.94 | $4.48 |
Technical Indicators
Market Signals| Indicator | BDTX | BMHL |
|---|---|---|
| Relative Strength Index (RSI) | 75.48 | 50.59 |
| Support Level | $3.02 | $3.24 |
| Resistance Level | $3.37 | $3.89 |
| Average True Range (ATR) | 0.16 | 0.19 |
| MACD | 0.08 | 0.00 |
| Stochastic Oscillator | 90.95 | 84.09 |
Price Performance
Historical ComparisonAbout BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
About BMHL Bluemount Holdings Limited Class B Ordinary Shares
Bluemount Holdings Ltd through its operating subsidiaries, it is a Hong Kong-based consulting and advisory and financial services provider, as well as trader of commodities such as luxury timepieces. The financial services includes underwriting and placing services, securities dealing and brokerage services, and asset management services. It provides comprehensive consulting and advisory services on business development strategies to its diverse clientele. Generally, the company provides consulting and advisory business for the following segments: Corporate Finance; and Strategic Communications.